Acme India (ACMERAIL) Q2 FY27's Revenue Triples, But Profitability Hinges on H2 Execution
Acme India's Q2 revenue surged 208% year-on-year to ₹74 crore, but a net loss of ₹10 crore underscores the company's seasonal billing and high fixed costs.
Acme India Industries reported a 208% surge in Q2 FY27 revenue, driven by railway tenders. However, a net loss of ₹10 crore highlights the strain of fixed costs against low seasonal billing. Management's guidance for a 4x revenue jump in the second half now becomes the critical test.
For a railway coach supplier, the story is always about converting a massive order book into timely, profitable billings. Acme India's first post-IPO quarter delivered the classic tension: revenue tripled year-on-year to ₹74 crore, yet the company posted a ₹10 crore net loss. The numbers reflect a structural seasonality where most work is billed in the year's final months, leaving the first half to absorb full fixed costs.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr), Q2 FY26 (Sep 2025): 24.0
Revenue (₹ Cr), Q2 FY27 (Sep 2026): 74.0
Profit (₹ Cr), Q2 FY26 (Sep 2025): -20.0
Profit (₹ Cr), Q2 FY27 (Sep 2026): -10.0
Revenue (₹ Cr)
Revenue (₹ Cr), Q2 FY26 (Sep 2025): 24.0
Revenue (₹ Cr), Q2 FY27 (Sep 2026): 74.0
Profit (₹ Cr)
Profit (₹ Cr), Q2 FY26 (Sep 2025): -20.0
Profit (₹ Cr), Q2 FY27 (Sep 2026): -10.0
Metric
CurrentQ2 FY27 (Sep 2026)
PreviousQ2 FY26 (Sep 2025)
Revenue (₹ Cr)
74.0
24.0
Profit (₹ Cr)
-10.0
-20.0
Net Profit Margin (%)
-13.5
—
While the loss narrowed from ₹20 crore a year ago, the negative margin of 13.5% shows how far profitability lags behind top-line growth. Total expenses rose 87% year-on-year, with interest costs doubling to ₹8 crore, as reported by StockWatch.
The H2 Pivot Point
The entire investment case now rests on the second half. Management, in its earnings call, guided for H2 FY27 revenue between ₹310 and ₹325 crore—a more than four-fold jump from the first half. This target is anchored to a robust order book of ₹727 crore, which is 2.8 times last year's full revenue.
According to the transcript from MarketPing, 90-95% of this H2 turnover is expected from orders already in hand. The company also targets adding ₹1,200-1,500 crore of new orders over the next 12-15 months, providing multi-year visibility.
Live Chart
· ACMERAIL
(BSE)
ISIN: INE162701010
The Working Capital Trap
The credible order book is shadowed by a punishing working capital cycle. Receivables stretch 250 to 300 days, as payments are tied to final coach execution. This means the anticipated H2 revenue surge will create a significant cash drag well into the next fiscal year.
Management expects this cycle to normalize with monthly billing starting April 2027. Interest costs are also projected to fall, with full-year FY27 finance cost guided at ₹6-7 crore, down from ₹8 crore in H1, thanks to debt repayment from IPO proceeds.
Key Points
Revenue tripled year-on-year to ₹74 crore, but a net loss of ₹10 crore reveals severe margin pressure from fixed costs on low seasonal billing.
Management's guidance hinges on H2 FY27, targeting ₹310-325 crore in revenue from a strong ₹727 crore order book.
Profitability recovery depends on operating leverage in H2 and a critical improvement in the 250-300 day receivables cycle, which management aims to normalize by April 2027.
The stock's 33% decline from its all-time high, noted by StockWatch, prices in the execution risk against the visible order book opportunity.
“
Hexa Perspective
The quarter sets up a clear binary outcome. The order book visibility is tangible and government-backed, offering a credible path to the guided 4x revenue ramp. If executed, operating leverage should sharply improve margins from the current -13.5%.
The entire thesis, however, is contingent on two factors: flawless conversion of H2 billings and the promised normalization of the payment cycle by next April. The market's skepticism, reflected in the share price, is a rational discount for these execution and working capital risks. The next quarter's billing realization will be the first concrete signal of whether the guidance is achievable.
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
Frequently asked questions
What were Acme India Industries' Q2 FY27 results?
Acme India Industries reported a Q2 FY27 (September 2026 quarter) revenue of ₹74 crore, a 208% increase year-on-year. However, the company posted a net loss of ₹10 crore, though this was an improvement from a ₹20 crore loss in the same quarter last year.
Why did Acme India's profit decline despite huge revenue growth in Q2 FY27?
Acme India's profit remained negative despite a 208% revenue jump because the company incurred full fixed costs against seasonally low first-half billing. As per management commentary, H1 revenue of ₹74 crore was too low to absorb these costs, leading to a net loss. Profitability is expected only in the seasonally stronger second half.
What is Acme India's guidance for FY27?
Acme India's management has guided for full-year FY27 revenue of ₹380 crore, representing about 44% growth. This implies a second-half (H2 FY27) revenue target of ₹310-325 crore, a more than four-fold increase from H1's ₹74 crore, as stated in their earnings call.
What is Acme India's order book position as of Q2 FY27?
As of Q2 FY27, Acme India Industries reported an order book of ₹727 crore, which is about 2.8 times its FY26 revenue. Management expects this to grow to ₹1,200-1,500 crore over the next 12-15 months, providing strong multi-year visibility.
Why are Acme India's interest costs so high?
Acme India's interest cost doubled year-on-year to ₹8 crore in Q2 FY27. Management attributed part of this to MSME interest and accounting provisions. However, they expect costs to decline in H2 FY27 to a full-year target of ₹6-7 crore, aided by debt repayment from recent IPO proceeds.
What are the key risks facing Acme India Industries?
Key risks include heavy reliance on Indian Railways for revenue, a long 250-300 day receivables cycle straining working capital, and high customer concentration. Profitability is also contingent on executing a massive H2 revenue ramp from its current order book.
How did Acme India's stock react to the Q2 FY27 results?
According to analysis from StockWatch, Acme India's stock was down about 33% from its all-time high following the results, reflecting market skepticism about execution risks and working capital intensity, despite the visible order book opportunity.
What is Acme India's EBITDA margin guidance for FY27?
Acme India's management expects a sustainable EBITDA margin in the range of 17-18% for FY27. This is an improvement from the 16.2% EBITDA margin achieved in H1 FY27, driven by anticipated operating leverage in the second half.
What is Acme India's PAT margin guidance for FY27?
Management has guided for a PAT margin of 11-11.5% for FY27. This target is based on expected operating leverage from higher H2 revenue and lower interest costs following debt repayment from IPO funds.
What is the outlook for Acme India's receivables cycle?
Acme India's receivables cycle is currently 250-300 days, which strains working capital. Management expects this to normalize with the introduction of regular monthly billing starting in April 2027, which is critical for improving cash conversion and profitability.
Acme India Industries Q2 FY27 results August 2026
Acme India Industries announced its Q2 FY27 (quarter ended September 2026) results on 14 November 2026. The company reported revenue of ₹74 crore and a net loss of ₹10 crore for the quarter.
Acme India Industries Q2 FY27 earnings call
Acme India held its Q2 FY27 earnings call on 18 November 2026. Management guided for full-year FY27 revenue of ₹380 crore and H2 revenue of ₹310-325 crore, backed by an order book of ₹727 crore.
Acme India Industries order book Q2 FY27
Acme India Industries reported an order book of ₹727 crore as of Q2 FY27. Management expects this to grow to ₹1,200-1,500 crore over the next 12-15 months, providing strong visibility for future revenue.